Nassim Usma, Paul M. Meister

Premium
RXi Pharmaceuticals this week announced that Nassim Usman has joined its scientific advisory board. Usman is currently CEO and a director of Catalyst Biosciences. Prior to joining Catalyst, he was an entrepreneur-in-residence at Morgenthaler Ventures.
 
Usman previously held several positions during his 13-year tenure at Sirna. Usman is currently a member of the scientific advisory board of Noxxon Pharma.
 

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

In Nature this week: ash dieback disease fungal genome, and more.